The DOI matches its Crossref record; 251 of the 251 references it cites were found in a registry or an index.
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes
Open accessAbstract
Type 2 diabetes mellitus is characterized by the dysregulation of glucose homeostasis, resulting in hyperglycaemia. Although current diabetes treatments have exhibited some success in lowering blood glucose levels, their effect is not always sustained and their use may be associated with undesirable side effects, such as hypoglycaemia. Novel antidiabetic drugs, which may be used in combination with existing therapies, are therefore needed. The potential of specifically targeting the liver to normalize blood glucose levels has not been fully exploited. Here, we review the molecular mechanisms controlling hepatic gluconeogenesis and glycogen storage, and assess the prospect of therapeutically targeting associated pathways to treat type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–251 of 251
Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes
Handelsman, Y. (2011) · Diabetes Care · doi:10.2337/dc11-s237 · Cited by 84
Arizmendi, C., Liu, S., Croniger, C. M., Poli, V., & Friedman, J. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13033 · Cited by 83
Bench-to-bedside review: glucose production from the kidney.
Cano, N. (2002) · Critical Care · doi:10.1186/cc1517 · Cited by 82
Wu, C., Okar, D. A., Newgard, C. B., & Lange, A. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11103 · Cited by 82
Sørensen, H., Brand, C. L., Neschen, S., Holst, J. J., Fosgerau, K., Nishimura, E., & Shulman, G. I. (2006) · Diabetes · doi:10.2337/db06-0222 · Cited by 81
Distinct C/EBPα motifs regulate lipogenic and gluconeogenic gene expression in vivo
Pedersen, T. Å., Bereshchenko, O., García-Silva, S., Ermakova, O. V., Kurz, E., Mandrup, S., Porse, B. T., & Nerlov, C. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601563 · Cited by 80
In vitro and in vivo suppression of gluconeogenesis by inhibition of pyruvate carboxylase
Bahl, J. J., Matsuda, M., DeFronzo, R. A., & BRESSLER, R. C. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00660-0 · Cited by 79
Swarbrick, M. M., Havel, P. J., Levin, A. A., Bremer, A. A., Stanhope, K. L., Butler, M., Booten, S. L., Graham, J. L., McKay, R. A., Murray, S. F., et al. (2009) · Endocrinology · doi:10.1210/en.2008-0885 · Cited by 77
Bailey, T. S. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.06.009 · Cited by 77
A link between hepatic glucose production and peripheral energy metabolism via hepatokines
Abdul-Wahed, A., Gautier‐Stein, A., Casteras, S., Soty, M., Roussel, D., Romestaing, C., Guillou, H., Tourette, J.-A., Plèche, N., Zitoun, C., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.05.005 · Cited by 77
Glucagon receptor antagonism induces increased cholesterol absorption
Guan, H.-P., Yang, X., Lu, K., Wang, S.-P., Castro-Perez, J. M., Previs, S., Wright, M., Shah, V., Herath, K., Xie, D., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m060897 · Cited by 76
Derosa, G., & Maffioli, P. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.04.012 · Cited by 76
CITED2 links hormonal signaling to PGC-1α acetylation in the regulation of gluconeogenesis
Sakai, M., Matsumoto, M., Tujimura, T., Yongheng, C., Noguchi, T., Inagaki, K., Inoue, H., Hosooka, T., Takazawa, K., Kido, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2691 · Cited by 73
Bandsma, R., Wiegman, C., Herling, A. W., Burger, H.-J., ter Harmsel, A., Meijer, A. J., Romijn, J. A., Reijngoud, D., & Kuipers, F. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2591 · Cited by 72
The Coactivator SRC-1 Is an Essential Coordinator of Hepatic Glucose Production
Louet, J., Chopra, A. R., Sagen, J. V., An, J., York, B., Tannour‐Louet, M., Saha, P. K., Stevens, R. D., Wenner, B. R., Ilkayeva, O., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.009 · Cited by 71
Dang, Q., Kasibhatla, S. R., Xiao, W., Liu, Y., DaRe, J., Taplin, F., Reddy, K. R., Scarlato, G. R., Gibson, T., van Poelje, P. D., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901420x · Cited by 69
Owen, C., Lees, E. K., Grant, L., Zimmer, D. J., Mody, N., Bence, K. K., & Delibegović, M. (2013) · Diabetologia · doi:10.1007/s00125-013-2992-z · Cited by 67
Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy
Clar, J., Gri, B., Caldéraro, J., Birling, M., Hérault, Y., Smit, G., Mithieux, G., & Rajas, F. (2014) · Kidney International · doi:10.1038/ki.2014.102 · Cited by 67
van Poelje, P. D., Potter, S. C., & Erion, M. D. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_12 · Cited by 66
Choosing between GLP-1 Receptor Agonists and DPP-4 Inhibitors: A Pharmacological Perspective
Brown, D. X., & Evans, M. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/381713 · Cited by 66
Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors
Ogawa, A. K., Willoughby, C. A., Bergeron, R., Ellsworth, K. P., Geissler, W. M., Myers, R. W., Yao, J., Harris, G., & Chapman, K. T. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00798-4 · Cited by 65
Kiyosue, A., Hayashi, N., Komori, H., Leonsson‐Zachrisson, M., & JOHNSSON, E. K. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12100 · Cited by 62
Intestinal gluconeogenesis: key signal of central control of energy and glucose homeostasis
Mithieux, G., Andréelli, F., & Magnan, C. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32832c4d6a · Cited by 59
Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor
Tracey, W. R., Treadway, J. L., Magee, W. P., Sutt, J. C., McPherson, R. K., Levy, C. B., Wilder, D. E., Yu, L. J., Chen, Y., Shanker, R. M., et al. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00652.2003 · Cited by 58
Qiao, L., MacDougald, O. A., & Shao, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603038200 · Cited by 57
Protein tyrosine phosphatase 1B (PTP1B): A key regulator and therapeutic target in liver diseases
Chen, P., Cai, S.-P., Huang, C. Z., Meng, X., & Li, J. (2015) · Toxicology · doi:10.1016/j.tox.2015.08.006 · Cited by 53
PTP1B inhibitor Ertiprotafib is also a potent inhibitor of IκB kinase β (IKK-β)
Shrestha, S., Bhattarai, B. R., Cho, H., Choi, J., & Cho, H. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.03.001 · Cited by 51
Increasing fructose 2,6-bisphosphate overcomes hepatic insulin resistance of type 2 diabetes
Wu, C., Okar, D. A., Newgard, C. B., & Lange, A. J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2002.282.1.e38 · Cited by 48
Codogno, P., & Meijer, A. J. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.031 · Cited by 46
USP7 Attenuates Hepatic Gluconeogenesis Through Modulation of FoxO1 Gene Promoter Occupancy
Hall, J. A., Tabata, M., Rodgers, J. T., & Puigserver, P. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1420 · Cited by 46
Self-citationCdkn2a/p16Ink4a Regulates Fasting-Induced Hepatic Gluconeogenesis Through the PKA-CREB-PGC1α Pathway
Bantubungi, K., Hannou, S. A., Caron, S., Vallez, E., Baron, M., Lucas, A., Bouchaert, E., Paumelle, R., Tailleux, A., & Staels, B. (2014) · Diabetes · doi:10.2337/db13-1921 · Cited by 45
Kazierad, D. J., Bergman, A., Tan, B., Erion, D. M., Somayaji, V., Lee, D. S., & Rolph, T. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12672 · Cited by 44
Rivera, N., Grueter, C. A., Edgerton, D. S., Rodewald, T., Neal, D. W., Nishimura, E., Larsen, M. O., Jacobsen, L. O., Kristensen, K., Brand, C. L., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.115717 · Cited by 43
Katz, L., Manamley, N., SNYDER, W. J., Dodds, M., Agafonova, N., Sierra‐Johnson, J., Cruz, M. L., Kaur, P. P., Mudaliar, S., Raskin, P., et al. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12586 · Cited by 43
Technology evaluation: ISIS-113715, Isis.
Liu, G. (2004) · PubMed · Cited by 39
Erion, D. M., Lapworth, A. L., Amor, P. A., Bai, G., Vera, N. B., Clark, R. W., Yan, Q., Zhu, Y., Ross, T. T., Purkal, J. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097139 · Cited by 38
Tanaka, H., Nagashima, T., Shimaya, A., Urano, Y., Shimokawa, T., & Shibasaki, M. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.07.018 · Cited by 38
Small molecules that target phosphorylation dependent protein–protein interaction
Watanabe, N., & Osada, H. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.03.023 · Cited by 38
Sajan, M. P., Acevedo-Duncan, M. E., Standaert, M. L., Ivey, R. A., Lee, M., & Farese, R. V. (2014) · Diabetes · doi:10.2337/db13-1863 · Cited by 37
Early Identification of Type 2 Diabetes
Narayan, K. M. V., Chan, J. C. N., & Mohan, V. (2010) · Diabetes Care · doi:10.2337/dc10-1952 · Cited by 36
A new class of glycogen phosphorylase inhibitors
Lu, Z., Bohn, J., Bergeron, R., Deng, Q., Ellsworth, K. P., Geissler, W. M., Harris, G., McCann, P. E., McKeever, B. M., Myers, R. W., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.08.046 · Cited by 35
Zhi, J., & Zhai, S. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.589 · Cited by 34
Torres, T. P., Sasaki, N., Donahue, E. P., Lacy, B., Printz, R. L., Cherrington, A. D., Treadway, J. L., & Shiota, M. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.177899 · Cited by 31
α- and β-Cell Responses to Small Changes in Plasma Glucose in the Conscious Dog
Flattem, N. L., Igawa, K., Shiota, M., Emshwiller, M., Neal, D. W., & Cherrington, A. D. (2001) · Diabetes · doi:10.2337/diabetes.50.2.367 · Cited by 31
Kadiri, S., Monnier, C., Ganbold, M., Ledent, T., Capeau, J., & Antoine, B. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00518.2014 · Cited by 30
Role of glucagon in countering hypoglycemia induced by insulin infusion in dogs
Dobbins, R. L., Connolly, C. C., Neal, D. W., Palladino, L. J., Parlow, A. F., & Cherrington, A. D. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.261.6.e773 · Cited by 29
O'Harte, F. P. M., Franklin, Z. J., & Irwin, N. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12360 · Cited by 27
Novel therapeutics and targets for the treatment of diabetes
Aicher, T. D., Boyd, S. A., McVean, M., & Celeste, A. J. (2010) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.1 · Cited by 21
FR258900, a Novel Glycogen Phosphorylase Inhibitor Isolated from Fungus No. 138354
Furukawa, S., Murakami, K., NISHIKAWA, M., Nakayama, O., & Hino, M. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.67 · Cited by 20
FR258900, a Novel Glycogen Phosphorylase Inhibitor Isolated from Fungus No. 138354
Furukawa, S., TSURUMI, Y., Murakami, K., Nakanishi, T., Ohsumi, K., Hashimoto, M., NISHIKAWA, M., Takase, S., Nakayama, O., & Hino, M. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.66 · Cited by 12
Tiraidis, C., Alexacou, K.-M., Zographos, S. E., Leonidas, D. D., Gimisis, T., & Oikonomakos, N. G. (2007) · Protein Science · doi:10.1110/ps.072925607 · Cited by 11
Cited by
Islam, M. T., Tuday, E., Allen, S., Kim, J., Trott, D. W., Holland, W. L., Donato, A. J., & Lesniewski, L. A. (2023) · Aging Cell · doi:10.1111/acel.13767 · Cited by 313
VerPlank, J. J. S., Lokireddy, S., Zhao, J., & Goldberg, A. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809254116 · Cited by 122
Momordica charantia: A popular health-promoting vegetable with multifunctionality
Wang, S., Li, Z., Yang, G., Ho, C.-T., & Li, S. (2017) · Food & Function · doi:10.1039/c6fo01812b · Cited by 104
Efficacy of telemedicine on glycaemic control in patients with type 2 diabetes: A meta-analysis
De Groot, J., Wu, D., Flynn, D., Robertson, D., Grant, G., & Sun, J. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i2.170 · Cited by 77
SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic control
Montgomery, M. K., Bayliss, J., Devereux, C., Bezawork-Geleta, A., Roberts, D., Huang, C., Schittenhelm, R. B., Ryan, A., Townley, S. L., Selth, L. A., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz8048 · Cited by 63
Metadata
- Authors
- Rines, A. K., Sharabi, K., Tavares, C. D. J., & Puigserver, P.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2016-08-12
- Volume
- 15
- Issue
- 11
- Pages
- 786-804
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2509220708
- Cited by
- 375
- References
- 251
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.